-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UwyVQBPSFYkLdK/fY0gB1ZzpZvDu05lTN3zzO+8/v+Vv9f/5Ic4tg6TUkHZxL9wx ldzfKRK7UTjsXVKf01YlOA== 0000904454-04-000021.txt : 20040113 0000904454-04-000021.hdr.sgml : 20040113 20040113124352 ACCESSION NUMBER: 0000904454-04-000021 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040113 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENCORE MEDICAL CORP CENTRAL INDEX KEY: 0000944763 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 650572565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49628 FILM NUMBER: 04522181 BUSINESS ADDRESS: STREET 1: 9800 METRIC BOULEVARD STREET 2: P O BOX 1900 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 5128329500 MAIL ADDRESS: STREET 1: 9800 METRIC BOULEVARD STREET 2: P O BOX 1900 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 19950531 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GALEN PARTNERS III L P CENTRAL INDEX KEY: 0001034486 IRS NUMBER: 133930452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 SC 13D/A 1 s13da_0108-2004encore.txt ENCORE MEDICAL CORP. SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)1 Encore Medical Corporation -------------------------- (Name of Issuer) Common Stock, $.001 par value ----------------------------- (Title of Class of Securities) 29256E 10 9 ----------- (CUSIP Number) Bruce F. Wesson Merrill A. Ulmer, Esq. Galen Associates Ropes & Gray LLP 610 Fifth Avenue 45 Rockefeller Plaza New York, New York 10020 New York, New York 10111 Tel. (212) 218-4990 Tel. (212) 841-5700 --------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 14, 2003 ---------------------------------------------------- (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ]. - ------------------- 1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 29256E 10 9 Page 2 of 8 Pages 1) Name of Reporting Person: Galen Partners III, L.P. and I.R.S. Identification No. of Above Person, if an Entity (Voluntary): - ---------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ---------------------------------------------- 3) SEC Use Only - ---------------------------------------------- 4) Source of Funds Not Applicable - ---------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ---------------------------------------------- 6) Citizenship or Place of Organization Delaware - ---------------------------------------------- Number of 7) Sole Voting 9,216,432 shares of Shares Beneficially Power Common Stock (including Owned by shares issuable upon Reporting Person: exercise of warrants) ---------------------------------------------- 8) Shared Voting Power -0- ---------------------------------------------- 9) Sole Disposi- 9,216,432 shares of tive Power Common Stock (including shares issuable upon exercise of warrants) ---------------------------------------------- 10) Shared Dis- positive Power -0- ---------------------------------------------- 11) Aggregate Amount 9,216,432 shares of Beneficially Owned by Common Stock (including Each Reporting Person shares issuable upon exercise of warrants) - --------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - --------------------------------------------------------------------------- 13) Percent of Class Represented by 21.3% Amount in Row (11) - --------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 29256E 10 9 Page 3 of 8 Pages 1) Name of Reporting Person: Galen Partners International III, L.P. and I.R.S. Identification No. of Above Person, if an Entity (Voluntary): - ---------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ---------------------------------------------- 3) SEC Use Only - ---------------------------------------------- 4) Source of Funds Not Applicable - ---------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ---------------------------------------------- 6) Citizenship or Place of Organization Delaware - ---------------------------------------------- Number of 7) Sole Voting 834,204 shares of Shares Beneficially Power Common Stock (including Owned by shares issuable upon Reporting Person: exercise of warrants) ---------------------------------------------- 8) Shared Voting Power -0- ---------------------------------------------- 9) Sole Disposi- 834,204 shares of tive Power Common Stock (including shares issuable upon exercise of warrants) ---------------------------------------------- 10) Shared Dis- positive Power -0- ---------------------------------------------- 11) Aggregate Amount Beneficially 834,204 shares of Owned by Each Reporting Person Common Stock (including shares issuable upon exercise of warrants) - --------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - --------------------------------------------------------------------------- 13) Percent of Class Represented by 2.0% Amount in Row (11) - --------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 29256E 10 9 Page 4 of 8 Pages 1) Name of Reporting Person: Galen Employee Fund III, L.P. and I.R.S. Identification No. of Above Person, if an Entity (Voluntary): - ---------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ---------------------------------------------- 3) SEC Use Only - ---------------------------------------------- 4) Source of Funds Not Applicable - ---------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ---------------------------------------------- 6) Citizenship or Place of Organization Delaware - ---------------------------------------------- Number of 7) Sole Voting 38,088 shares of Shares Beneficially Power Common Stock (including Owned by shares issuable upon Reporting Person: exercise of warrants) ---------------------------------------------- 8) Shared Voting Power -0- ---------------------------------------------- 9) Sole Disposi- 38,088 shares of tive Power Common Stock (including shares issuable upon exercise of warrants) ---------------------------------------------- 10) Shared Dis- positive Power -0- ---------------------------------------------- 11) Aggregate Amount 38,088 shares of Beneficially Owned by Common Stock (issuable upon exercise of warrants) - --------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - --------------------------------------------------------------------------- 13) Percent of Class Represented by less than 0.1% Amount in Row (11) - --------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 29256E 10 9 Page 5 of 8 Pages 1) Name of Reporting Person: Galen Advisors, LLC and I.R.S. Identification No. of Above Person, if an Entity (Voluntary): - ---------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ---------------------------------------------- 3) SEC Use Only - ---------------------------------------------- 4) Source of Funds Not Applicable - ---------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ---------------------------------------------- 6) Citizenship or Place of Organization Delaware - ---------------------------------------------- Number of 7) Sole Voting 63,492 shares of Shares Beneficially Power Common Stock Owned by Reporting Person: ---------------------------------------------- 8) Shared Voting Power -0- ---------------------------------------------- 9) Sole Disposi- 63,492 shares of tive Power Common Stock ---------------------------------------------- 10) Shared Dis- positive Power -0- ---------------------------------------------- 11) Aggregate Amount 63,492 shares of Beneficially Owned by Common Stock Each Reporting Person - --------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - --------------------------------------------------------------------------- 13) Percent of Class Represented by 0.1% Amount in Row (11) - --------------------------------------------------------------------------- 14) Type of Reporting Person CO CUSIP No. 29256E 10 9 Page 6 of 8 Pages Amendment No. 1 to Schedule 13D ------------------------------- Reference is hereby made to the statement on Schedule 13D filed with the Securities and Exchange Commission (the "Commission") on June 20, 2001. Terms defined in the Schedule 13D are used herein as so defined. The following items of the Schedule 13D are hereby amended as follows: Item 2. Identity and Background ----------------------- Item 2 is hereby amended to add Galen Advisors, LLC, a Delaware limited liability company ("GA"), as a Reporting Person. Messrs. Wesson, Grant and Wilkerson are the Managing Members of GA, whose principal business is that of an investment manager. Item 3. Source and Amount of Funds or Other Consideration ------------------------------------------------- Item 3 is hereby amended by adding the following thereto: On August 14, 2003, warrants to purchase 502,129, 45,449 and 2,076 shares of Common Stock (collectively, the "Warrants") were assigned to Galen, Galen Intl and GEF, respectively, by the Issuer's lender pursuant to a pre-existing agreement between such Reporting Persons and the lender. The lender had agreed to transfer the Warrants if certain events occurred and a specified portion of the indebtedness owed by the Issuer to the lender was prepaid. The Warrants were exercisable immediately upon their assignment, for $.01 per share, and expire on February 8, 2009. Item 5. Interest in Securities of the Issuer ------------------------------------ Item 5 is hereby amended and restated to read in its entirety as follows: The following information is based on a total of 42,710,000 shares of Common Stock outstanding, and gives effect to the exercise of all Warrants held by each entity and person named below. All shares of Series A Preferred Stock held by the Reporting Persons were converted to Common Stock on August 11, 2003. (a) Galen ----- Galen owns 9,216,432 shares of Common Stock, or approximately 21.3% of the Common Stock outstanding. Claudius, as the general partner of Galen, may be deemed to beneficially own the securities owned by Galen. Galen Intl ---------- Galen Intl owns 834,204 shares of Common Stock, or approximately 2.0% of the Common Stock outstanding. Claudius, as the general partner of Galen Intl, may be deemed to beneficially own the securities owned by Galen Intl. GEF --- GEF owns 38,088 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. Wesson Enterprises, as the general partner of GEF, may be deemed to beneficially own the securities owned by GEF. CUSIP No. 29256E 10 9 Page 7 of 8 Pages GA -- GA owns 63,492 shares of Common Stock, or approximately 0.1% of the Common Stock outstanding. Other Related Persons --------------------- (i) Bruce F. Wesson directly beneficially owns 65,184 shares of Common Stock (including 15,000 shares issuable upon the exercise of presently-exercisable stock options) and indirectly beneficially owns (through a trust for the benefit of his children) 17,500 shares, or in the aggregate approximately 0.2% of the Common Stock outstanding. (i) Zubeen Schroff directly beneficially owns 15,000 shares of Common Stock (issuable upon the exercise of presently-exercisable stock options), or less than 0.1% of the Common Stock outstanding. (b) The members of Claudius may be deemed to share the power to vote or direct the voting of and to dispose or direct the disposition of the securities of the Issuer owned by Galen and Galen Intl. Bruce F. Wesson, the President and sole director of Wesson Enterprises, may be deemed to have sole power to vote or direct the voting of and to dispose or direct the disposition of, the securities of the Issuer held by GEF. The managing members of GA may be deemed to share the power to vote or direct the voting of and to dispose or direct the disposition of the securities of the Issuer held by GA. Each of the members of Claudius, Mr. Wesson and the managing members of GA disclaims beneficial ownership of all securities other than those he owns directly or by virtue of his indirect interest in the securities owned by Galen, Galen Intl, GEF and/or GA. (c) In connection with the Issuer's public offering of Common Stock that closed on December 16, 2003 and the related over-allotment option, the Reporting Persons sold shares of Common Stock, at the public offering price of $6.25 per share, as follows: Date Seller Number of Shares Sold ---- ------ --------------------- December 16, 2003 Galen 1,506,216 December 16, 2003 Galen Intl 136,332 December 16, 2003 GEF 6,225 December 18, 2003 Galen 956,172 December 18, 2003 Galen Intl 86,546 December 18, 2003 GEF 3,952 (d) Except as described in this statement, no person has the power to direct the receipt of dividends on or the proceeds of sales of the shares of Common Stock owned by the Reporting Persons. (e) Not applicable. CUSIP No. 29256E 10 9 Page 8 of 8 Pages Signature --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. GALEN PARTNERS III, L.P. By: Claudius, LLC, General Partner By: /s/ Bruce F. Wesson -------------------- Managing Member GALEN PARTNERS INTERNATIONAL III, L.P. By: Claudius, LLC, General Partner By: /s/ Bruce F. Wesson -------------------- Managing Member GALEN EMPLOYEE FUND III, L.P. By: Wesson Enterprises, Inc., General Partner By: /s/ Bruce F. Wesson -------------------- President GALEN ASSOCIATES, LLC By: /s/ Bruce F. Wesson -------------------- Managing Member Dated: January 8, 2004 -----END PRIVACY-ENHANCED MESSAGE-----